USPTO trademark

SANGRAIL

Opposition periodUSPTOWord markClass 5Class 42

"SANGRAIL" is a word mark owned by Sangrail Biologics Inc., filed at the USPTO on January 22, 2026. It is in its opposition period and covers classes 5 and 42.

Get this data via the API
Official USPTO record
SANGRAIL trademark as filed
As filed with the USPTO
Status
Opposition period
Since August 10, 2026
Filed
January 22, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99608993
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns SANGRAIL

The owner and representative on file with the office.

Owner

Sangrail Biologics Inc.

Philadelphia, United States

Representative

Jacqueline Lesser

Ice Miller LLP

Goods and services

What the mark covers

The products and services SANGRAIL is filed for, grouped by Nice class.

  • Pharmaceutical preparations for treatment of rare genetic diseases; pharmaceutical preparations primarily comprising cells for treatment of rare diseases; pharmaceutical preparations and therapeutic agents for use in gene therapy for treatment of rare diseases; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases.

  • Medical and scientific research in the field of gene therapy; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; Research and development of pharmaceuticals using gene editing

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Extension of time to oppose received
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Teas/email correspondence entered
  7. Correspondence received in law office
  8. Teas response to office action received
  9. Notification of non-final action e-mailed
  10. Non-final action e-mailed

5 earlier steps on the official record.

FAQ

About SANGRAIL

Who owns the trademark "SANGRAIL"?

The USPTO trademark "SANGRAIL" (application 99608993) is owned by Sangrail Biologics Inc.

What is the status of "SANGRAIL"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SANGRAIL and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b91-7986-718a-ae25-e8b242fb5ac1
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b91-7986-718a-ae25-e8b242fb5ac1",
  "object": "trademark",
  "mark_text": "SANGRAIL",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "99608993",
  "filing_date": "2026-01-22",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Sangrail Biologics Inc.",
      "entity_id": null
    }
  ]
}